The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
about
Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated FibroblastsRapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cellsRegulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment.Anticancer agents interacting with membrane glucose transporters.Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models.Oncogenic regulation of tumor metabolic reprogramming.The Glycolytic Switch in Tumors: How Many Players Are Involved?Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer.Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway.WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2.Cancer and Exercise: Warburg Hypothesis, Tumour Metabolism and High-Intensity Anaerobic Exercise.Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
P2860
Q28078990-FB917BF9-CBD4-49D1-8058-31E74FAD1653Q33759313-31E61331-462C-4664-B1D8-253A5E0D4AF5Q33919290-58F5DE3D-C2BD-4D6E-838A-FD2B9BCEF40DQ37662131-3B61524D-B7B4-4E52-9097-438C771310CBQ37694431-8D6AFAF7-251E-4B76-962A-23C8E929BDCFQ39064468-3B111EF4-B792-4414-B582-EE6862E79738Q41781449-2FFCCD17-ED87-4D39-B994-11ED148BD532Q42321596-C534E187-2968-45C5-9C5A-652BC75E98D9Q45419184-9306C42B-15EC-433B-9645-1C58F57D2605Q47420917-7C307EA5-F565-4F12-A50A-591E50B68824Q48049656-AF107E04-E4AC-4BBC-B250-DC98FAB9900AQ48189669-6B9252DD-0BD1-42FB-9DDA-931ABD96AC52Q50074585-7C676804-DE05-4C2E-9D86-95C6FCEE3071Q52663598-2B5178F8-F24C-4BA2-A494-CE59F7523D83Q52678274-C3B5D3BE-E878-4BC6-A6AE-CC75FEACB3E5Q54121259-1F70DCF3-E92B-4D97-AE9D-7D0D093B01BCQ55317070-D6631A19-6BA1-4512-B0B1-2E3F0C28E73BQ58562101-C25BE8B4-15B6-4DF7-84BA-DCEBC1A751C6
P2860
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@ast
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@en
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@nl
type
label
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@ast
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@en
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@nl
prefLabel
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@ast
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@en
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
@en
P2093
P2860
P3181
P356
10.18632/ONCOTARGET.7676
P407
P5008
P577
2016-02-24T00:00:00Z
2016-06-21T00:00:00Z